SimaniLTozluCLeeS, et al. Longitudinal investigation of neuroimaging changes related to memory decline in multiple sclerosis: Testing a mechanistic model. Mult Scler2025; 31(2): 207–217.
2.
Coll-MartinezCSalavedra-PontJBuxóM, et al. Differences in metacognition between multiple sclerosis phenotypes: Cognitive impairment and fatigue are key factors. Front Psychol2023; 14: 1163112.
3.
LindvallEAbzhandadzeTQuinnTJ, et al. Is the difference real, is the difference relevant: The minimal detectable and clinically important changes in the Montreal Cognitive Assessment. Cereb Circ Cogn Behav2024; 6: 100222.
4.
RoccaMASchoonheimMMValsasinaP, et al. Task- and resting-state fMRI studies in multiple sclerosis: From regions to systems and time-varying analysis. NeuroImage Clin2022; 35: 103076.
5.
MoratóXMarquiéMTartariJP, et al. A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress. Sci Rep2023; 13(1): 5406.
